Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-09

Clinical Trial Update: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates for ciclosporin in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) have completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclosporin (cyclosporine)

Snippet

Sponsor: Imperial College London | Conditions: HTLV I Associated Myelopathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-09